Skip to main content

Nonprofit · EIN 51-0629988

STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC

Tax-exempt · BOYNTON BEACH, FL 33437

Financials

$15K$37K2023$15K$75K2024
Revenue Expenses · by fiscal year end
Financials of STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$15,124$74,726-$59,602$499,251$4,105$495,146
December 31, 2023990$14,514$36,558-$22,044$559,018$4,270$554,748
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$499
Program service revenue
$0
Investment income
$14,625
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Occupancy
$2,500
Program services (functional)
$74,365
Management and general (functional)
$361

Balance sheet and other

Total assets, start of year
$559,018
Total assets, end of year
$499,251
Total liabilities, end of year
$4,105
Net assets, end of year
$495,146
Land, buildings and equipment
$15,105
Gross receipts
$15,124
Employees
0
Year formed
2007
State of legal domicile
FL

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
SUSAN MAHARAJDIRECTOR
Trustee or director
1$0
DANIEL MANGRUDIRECTOR
Trustee or director
1$0
DIPNARINE MAHARAJ MDPRESIDENT, D
Trustee or director, Officer
6$0
JACQUELINE GOUVEA MDSECRETARY, T
Trustee or director, Officer
4$0
CLAUDIA OLIVEIRADIRECTOR
Trustee or director
1$0
RICHARD SIMONDIRECTOR
Trustee or director
1$0
TYLER SMILEYDIRECTOR
Trustee or director
1$0
TERRELL W WITCHERDIRECTOR
Trustee or director
2$0
990 for the year ended December 31, 2023: 8 people
NameTitleHours / weekCompensation
SUSAN MAHARAJDIRECTOR
Trustee or director
1$0
DANIEL MANGRUDIRECTOR
Trustee or director
1$0
DIPNARINE MAHARAJ MDPRESIDENT, D
Trustee or director, Officer
6$0
JACQUELINE GOUVEA MDSECRETARY, T
Trustee or director, Officer
4$0
CLAUDIA OLIVEIRADIRECTOR
Trustee or director
1$0
RICHARD SIMONDIRECTOR
Trustee or director
1$0
TYLER SMILEYDIRECTOR
Trustee or director
1$0
TERRELL W WITCHERDIRECTOR
Trustee or director
2$0

Address and contacts

Address (IRS master file)
10301 HAGEN RANCH RD STE 700, BOYNTON BEACH, FL 33437-3734
In care of
% DIPNARINE MAHARAJ
Principal officer (990 for 2024)
DIPNARINE MAHARAJ MD, 10301 HAGEN RANCH ROAD SUITE 700, BOYNTON BEACH, FL 33437
Signed the 990
DIPNARINE MAHARAJ MD, PRESIDENT, DIRECTOR
Phone
(561) 752-5522
Return prepared by
WITCHER & STEWART PA

Mission

THE ORGANIZATION IS TO BE OPERATED FOR SCIENTIFIC AND EDUCATIONAL PURPOSES TO CONDUCT RESEARCH TO UNCOVER THE MOLECULAR BASIS OF CANCER AND DEGENERATIVE DISEASE WITH THE EMPHASIS ON CANCER INCLUDING MULTIPLE MYELOMA AND OTHER CHRONIC DISEASES INCLUDING FRAILTY.

990 for the year ended December 31, 2024

Program accomplishments

  • IN MAY 2008 THE ORGANIZATION STARTED A COLLABORATION WITH SCIENTISTS AT WAKE FOREST UNIVERSITY WHO HAVE DEVELOPED A PROTOCOL FOR USING GRANULOCYTES FOR TREATING SOLID TUMRORS. THE PROTOCOL WAS MODIFIED FOR IMPLEMENTATION AND INVESTIGATIONAL NEW DRUG APPROVAL WAS OBTAINED IN OCTOBER 2008 FOR A PHASE I/II CLINICAL TRIAL FOR 29 PATIENTS. WESTERN INSTITUTIONAL REVIEW BOARD APPROVAL WAS OBTAINED IN NOVEMBER 2008. THROUGH 2024, 17 PATIENTS HAVE BEEN TREATED AND 260 DONORS HAVE BEEN EVALUATED.
    Expenses $74,365
  • YOUNG BLOOD CLINICAL STUDY UNDER FOOD AND DRUG ADMINISTRATION APPROVAL EVALUATING THE SAFETY AND EFFICACY OF FRESH FROZEN PLASMA (GMFFP) FROM YOUNG HEALTHY DONORS AGES 18 TO 35, WHO HAVE GRANULOCYTE - COLONY STIMULATING FACTOR (G-CSF) TO AMELIORATE FRAILTY AND ENHANCE THE IMMUNE RISK PROFILE IN OLDER INDIVIDUALS.

What it must file and when

IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
51-0629988
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2007
Accounting year ends
December
Files
Form 990-N (e-Postcard)
Category (NTEE)
Medical research (H90)
Assets (IRS master file)
$499,251
Income (IRS master file)
$15,124

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$15,124$74,726$499,251XML
990December 2023$14,514$36,558$559,018XML
990December 2022$18,013$94,674$580,762IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 51-0629988).

Questions about STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC

What is the EIN of STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC?
The employer identification number (EIN) of STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC is 51-0629988.
Is STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
Are donations to STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC file?
Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
When is the next return of STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC?
The 990 for the year ended December 31, 2024 names DIPNARINE MAHARAJ MD.
Who are the officers and directors of STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC?
The 990 for the year ended December 31, 2024 lists 8 people; 0 received compensation from the organization.
How much revenue does STEM CELL CANCER AND REGENERATIVE MEDICINE RESEARCH INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $15,124, expenses of $74,726 and total assets of $499,251 at year end.

Other nonprofits in BOYNTON BEACH

All nonprofits in BOYNTON BEACH · Florida · Medical research